• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Outsourcing in Drug Discovery

$2,062.00 – $4,152.00

Clear
SKU: KLI827058 Categories: Drug Delivery Market Reports, Drug Discovery Market Reports, Pharmaceuticals Market Research Pages: 258
  • Description
  • Table of Contents
  • Latest reports

Description

The number and scope of drug discovery outsourcing agreements has grown rapidly over the past five years, and the pace will accelerate over the next five years. Outsourcing is now an essential part of drug discovery. Major pharmas and biotechs are aggressively pursuing a range of outsourcing agreements. On the supplier side, smaller vendors rely on outsourcing revenues to pay their bills and boost their credibility.

Outsourcing in drug discovery is a popular topic for trade articles and seminars. These generally focus on who is doing what with whom for how much. This report will not cover this familiar territory. Instead it will provide a strategic view by showing what motivates clients and suppliers to do deals, what makes these deals successful or unsuccessful, what are the dimensions of this market, and what may be expected in the future.

The key issues addressed in this report include:

    • 1. What are the fundamental issues regarding outsourcing in drug discovery (ODD)?

 

    • 2. What are the key environmental factors that shape ODD?

 

    • 3. How large is the market for ODD and how fast is it growing?

 

    • 4. Which are the major groups of ODD services and how large are they?

 

    • 5. What do customers look for in a supplier? How do they evaluate them?

 

    • 6. What do suppliers do to attract clients? Which techniques work best?

 

    • 7. What types of ODD deals are being done and what are some examples?

 

    • 8. What makes a deal successful? What are the obstacles to avoid?

 

    • 9. Who are the leading ODD suppliers? What do they offer?

 

    10. Which of them has been successful? Which ones show the greatest promise?

 

Table of Contents

Chapter One: Executive Summary

  • Whats & Whys of Outsourcing
  • Understanding Drug Discovery
  • Report Objectives & Structure
  • Summary of Results

Chapter Two: Environment

  • Pharma Industry Problems & Expectations
  • Suppliers’ Issues & Objectives
  • Major CROs
  • Biotechs’ Issues
  • Outsourcing Strategies

Chapter Three: Markets for Outsourced Services

  • Pharmaceutical Industry Outsourcing
  • Outsourcing in the Drug Discovery Market
  • Biology Services
    • Types of Biology Services
    • Leading Suppliers
    • Market Size & Projected Growth
  • Chemistry Services
    • Types of Chemistry Services
    • Leading Suppliers
    • Market Size & Projected Growth
  • Screening Services
    • Leading Suppliers
    • Market Size & Growth
  • Lead Optimization Markets
    • Leading Suppliers
    • Market Size & Growth

 

Chapter Four: Outsourcing from the Customer Side

AstraZeneca Enabling Science & Technology

  • Global Enabling Science & Technology
  • Global Discovery Alliance
  • Refocusing Efforts

Bristol-Myers Squibb

  • How Does BMS Organize for Outsourcing?
  • How Does BMS Approach Outsourcing?
  • What Are the Stages of Outsourcing?
  • Best Practices in Outsourcing

Glaxo R&D

  • Identifying Building Blocks
  • In-House vs. Outsource
  • Selecting Products & Vendors
  • Measuring Results

Johnson & Johnson Pharmaceuticals Technology Licensing

  • J&J Outsourcing Organization
  • Active Areas of Interest
  • Types of Technology License Agreements
  • How J&J Selects Partners
  • Advice to Potential Partners

Eli Lilly External Development

  • Value of Outsourcing to Lilly
  • Approach to Outsourcing
  • Measuring Performance: Role of Metrics

Merck Strategic Research Initiatives

  • Identifying Opportunities
  • Approach to Partnering
  • Research Partnering Strategies

Millennium’s Technology Alliances

  • Millennium’s Alliances
  • Keys to Successful Alliances
  • Alliance Management
  • Management Techniques

Novartis Global Business Development

  • Preparing for Partnering
  • Picking the Partner
  • Doing the Deal
  • Making It Work

Pharmacia R&D Outsourcing

  • Why Pharmacia Outsources
  • Pharmacia’s Sourcing Department
  • What Pharmacia Outsources
  • Selecting the Vendor
  • Enhancing the Sourcing-Supplier Interface

Pfizer Global R&D

  • Reasons for Outsourcing
  • What Gets Outsourced?
  • Managing the Collaboration
  • Pitfalls to Avoid
  • Understanding Pfizer Values

Summary: What Customers Seek

  • Why Pharmas Outsource
  • Areas of Interest
  • Types of Agreements
  • How Partners are Selected
  • Making the Deal Work
  • Executing the Assignments

Chapter Five: Outsourcing from the Supplier Side

Affinium Pharmaceuticals

  • Building a Company for Partnering
  • What Affinium Offers
  • Alliances

ArQule, Inc.

  • Transforming ArQule
  • What ArQule Offers
  • Outsourcing Strategy

BioFocus plc

  • What BioFocus Offered
  • The Initial Deal
  • Benefits of Outsourcing

Genomics Collaborative

  • Global Repository
  • Pharmacogenomics: Pharmacia Alliance

Syngene International Pvt. Ltd.

  • Outsourcing in India
  • Working with CROs in Developing Countries

Successful Suppliers’ Strategies

  • Defining Who You Are
  • What Services to Provide
  • How to Attract Customers
  • Making the Deal Work

Chapter Six: Deal-Making In Drug Discovery

  • Market Drivers for Deal-Making
  • Valuation of Deals
  • Negotiating the Deal
  • Effective Alliance Management
  • Measuring the Effectiveness of a Deal
    • Key Factors for Success
    • Major Reasons for Failure
    • Alliance Outcomes
  • Examples of Successful Deals
    • Product Supply Contract
    • Fee-for-Service/ Full-Time Equivalent (FTE)
    • Collaborative Research Agreement
    • Non-exclusive Alliance
    • Exclusive Strategic Alliance

Chapter Seven: Supplier Profiles

Absorption Systems

  • Company History & Leadership
  • Drug Discovery Services
  • Outsourcing Relationships

Affinium

  • Company History & Leadership
  • Drug Discovery Services
  • Outsourcing Relationships

Albany Molecular Research, Inc.

  • Company History & Structure
  • Financials
  • Drug Discovery Services
  • Outsourcing Relationships

Ambit Biosciences

  • Company Background & Orientation.
  • Drug Discovery Technologies
  • Outsourcing Relationships

Argenta

  • Company History and Connections
  • Drug Discovery Services
  • Outsourcing Relationships

ArQule

  • Company History & Structure
  • Financials
  • Drug Discovery Services
  • Outsourcing Relationships

Array Biopharma

  • Company History & Objectives
  • Financials
  • Drug Discovery Services
  • Outsourcing Relationships

Aurigene

  • Company History & Management
  • Drug Discovery Services

BioFocus plc

  • Company History & Business Focus
  • Financials
  • Drug Discovery Services
  • Outsourcing Collaborations

Cardinal Health Pharmaceutical Development (Magellan Laboratories)

  • Company History & Structure
  • Financials
  • Drug Discovery Services
  • Outsourcing Relationships

Cell & Molecular Technologies

  • Company History & Structure
  • Financials
  • Drug Discovery Services

Cetek

  • Company History & Focus
  • Drug Discovery Services
  • Outsourcing Relationships

ChemBridge & CRL

  • Company Structure & Focus
  • Drug Discovery Products & Services
  • Outsourcing Relationships

Chemical Diversity

  • Company History & Focus
  • Drug Discovery Services
  • Customers

ChemShop BV

  • Company Focus & Capabilities
  • Drug Discovery Services

ComGenex Inc.

  • Company History & Focus
  • Drug Discovery Services
  • Outsourcing Research Partners

deCODE Genetics

  • Company Focus & Objectives
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

Discovery Partners International

  • Company History & Acquisitions
  • Financials
  • Drug Discovery Services
  • Outsourcing Partners

Evotec OAI

  • Company History & Structure
  • Financials
  • Drug Discovery Services
  • Outsourcing Partners

Genome Therapeutics

  • Company History & Focus
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

Genomics Collaborative

  • Company Focus & Objectives
  • Drug Discovery Services
  • Outsourcing & Research Partners

ICOS Corporation

  • Company Focus & Objectives
  • Financials
  • Research Partners

Lexicon Genetics, Inc.

  • Company Focus
  • Financials
  • Drug Discovery Services
  • Clients & Research Partners

MDS Pharma Services

  • Company History & Structure
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

Medarex, Inc.

  • Company Focus & Objectives
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

Millenium Pharmaceuticals

  • Company Focus & Objectives
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

MerLion Pharmaceuticals

  • Company Background & Objectives
  • Drug Discovery Services
  • Outsourcing Research Parnters

PharmaCore

  • Company Focus
  • Drug Discovery Services
  • Outsourcing Research Partners

Pharmacopeia

  • Company Focus & Ownership
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

Pharm-Eco

  • Company History & Focus
  • Financials
  • Drug Discovery Services

PPD, Inc.

  • Company Focus
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

PsychoGenics

  • Company Focus
  • Drug Discovery Services
  • Research Agreements

Quintiles

  • Company History & Focus
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

Sequitur

  • Company History & Focus
  • Drug Discovery Products & Services
  • Outsourcing Research Partners

Structural Bioinformatics, Inc.

  • Company History & Focus
  • Drug Discovery Services
  • Outsourcing Research Partners

Sunesis Pharmaceuticals

  • Company Focus
  • Drug Discovery Services
  • Outsourcing Research Partners

TransForm Pharmaceuticals

  • Company History & Focus:
  • Drug Discovery Services:
  • Outsourcing Research Partners

Tripos, Inc.

  • Company History & Focus
  • Financials
  • Drug Discovery Services
  • Outsourcing Research Partners

Vertex Pharmaceuticals Inc.

  • Company History & Focus
  • Financials
  • Drug Discovery Services
  • Development Partners

Zygogen, LLC

  • Company Focus & Objectives
  • Drug Discovery Service
  • Outsourcing Research Partner

Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

  • Figure 1-1: Outsourcing in Drug Discovery Market Summary Total Revenues and Growth Rate 2003-2007
  • Table 1-1: Market Share by Leading Suppliers 2002

Chapter Two: Environment

  • Table 2-1: Top CROs at a Glance

Chapter Three: Markets

  • Table 3-1: Outsourced and In-House Pharma R&D Expenditures, 1998-2007
  • Figure 3-1: Growth in Outsourced Portion of R&D Expenditures, 1998-2007
  • Table 3-2: Drug Discovery Outsourcing Market, 2002
  • Table 3-3: Drug Discovery Outsourcing Market Growth, 2003-2007
  • Table 3-4: Size and Growth of the Biology Services Outsourcing Market, 2003-2007
  • Figure 3-2: Biology Services Outsourcing Market Estimated Market Share by Leading Competitor, 2003
  • Table 3-5: Size and Growth of the Chemistry Services Outsourcing Market, 2003-2007
  • Figure 3-3: Chemistry Services Outsourcing Market Estimated Market Share by Leading Competitor, 2003
  • Table 3-6: Size and Growth of the Screening Services Outsourcing Market, 2003-2007
  • Figure 3-4: Screening Services Outsourcing Market Estimated Market Share by Leading Competitor, 2003
  • Table 3-7: Size and Growth of the Lead Optimization Services Outsourcing Market, 2003-2007
  • Figure 3-4: Lead Optimization Services Outsourcing Market Estimated Market Share by Leading Competitor, 2003

Chapter Four: From The Customer Side

  • Table 4-1: J&J’s Technology Licensing Agreements
  • Table 4-2: Do’s & Don’ts for Suppliers: 20 Tips for Success

Chapter Five: From The Supplier Side

  • Table 5-1: Types of Services Provided by Suppliers

Chapter Six: Deals

  • Table 6-1: Why Deals Succeed, Why Deals Fail

Chapter Seven: Profiles

  • Table 7-1: Outsourcing Companies’ Performance
  • Figure 7-1: Contract Drug Discovery Competition by Locations
  • Figure 7-2: Contract Drug Discovery Competition by Year Founded
  • Figure 7-3: Contract Drug Discovery Competition by Revenue
  • Figure 7-4: Contract Drug Discovery Competition by Number of Employees
  • Figure 7-5: Contract Drug Discovery Competition by Number of Clients
  • Figure 7-6: Contract Drug Discovery Competition by Services Offered

 

    The Market for Needle-Free Drug Delivery Systems
    July 14, 2016
    Transdermal and Transmucosal Drug Delivery Markets: Forecasts to 2020
    November 25, 2015
    The World Market for Implantable and Needle-Free Drug Delivery Systems
    December 11, 2013
    The World Market for Transdermal Drug Delivery
    September 13, 2012

Related products

  • Placeholder image

    Outsourcing in Drug Discovery

    $2,062.00 – $4,152.00
  • Placeholder image

    Advanced Drug Delivery: Technologies, Applications, and Markets

    $2,625.00 – $5,250.00
  • Placeholder image

    Neurologic Cancers: Selections from “The World Market for Neurotherapeutic Drugs”

    $1,121.00 – $1,717.00
  • Placeholder image

    Outsourcing in Drug Development – The Contract Research Market from Preclinical to Phase III

    $3,500.00 – $7,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Diabetes in Japan: The Markets for Monitoring, Insulin, Oral Hypoglycemics,...Wound Care Markets: Volume I: Skin Ulcers
Scroll to top